Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Prophylactic transfusion prevents strokes in children with sickle cell anemia who have abnormalities on transcranial Doppler ultrasonographic examination. However, it is not known how long transfusion should be continued in these children. METHODS: We studied children with sickle cell disease who had a high risk of stroke on the basis of a transcranial Doppler screening examination and who had received transfusions for 30 months or longer, during which time the Doppler readings became normal. The children were randomly assigned to continued transfusion or no continued transfusion. Children with severe stenotic lesions on cerebral magnetic resonance angiography were excluded. The composite primary end point was stroke or reversion to a result on Doppler examination indicative of a high risk of stroke. RESULTS: The study was stopped after 79 children of a planned enrollment of 100 underwent randomization. Among the 41 children in the transfusion-halted group, high-risk Doppler results developed in 14 and stroke in 2 others within a mean (+/-SD) of 4.5+/-2.6 months (range, 2.1 to 10.1) of the last transfusion. Neither of these events of the composite end point occurred in the 38 children who continued to receive transfusions. The average of the last two transcranial Doppler results before transfusion was started was the only predictor of the composite end point (P=0.05). CONCLUSIONS: Discontinuation of transfusion for the prevention of stroke in children with sickle cell disease results in a high rate of reversion to abnormal blood-flow velocities on Doppler studies and stroke. (ClinicalTrials.gov number, NCT00006182.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the approximately 22% of children who did not achieve normalization of transcranial Doppler velocity in spite of optimal transfusion in the trial were also protected from stroke (162).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [162]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D.-L., McKie, K., Figueroa, R., Litaker, M., Thompson, W., & Hess, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202273260905 · Cited by 658
Research works printed but not linked: 2
- Ohene-Frempong K, 1998, Blood, 91, 288
- Walters MC, 2000, Blood, 95, 1918
Cited by
Items 401–500 of 665
Choi, J., Markantonis, J., Simone, N. D., Nero, A. C., Kim, J., & Sarode, R. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22078 · Cited by 5
Blood Cell Disorders and the Nervous System
Merkler, A. E. (2020) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000858 · Cited by 5
Edjlali, M., Gobin-Metteil, M.-P., Mêlé, N., Maïer, B., Habibi, A., Kauv, P., Hosseini, H., Mas, J., Oppenheim, C., Galactéros, F., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26215 · Cited by 5
Novel approaches to measure transfusion effectiveness
Yee, M. E. M., & Fasano, R. M. (2023) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000783 · Cited by 5
Dokékias, A. E., & Basseila, G. B. (2010) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2010.06.027 · Cited by 5
Clinically‐oriented proteomic investigation of sickle cell disease: Opportunities and challenges
Renella, R. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500133 · Cited by 5
Imaging and Laboratory Diagnosis
Caplan, L. R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4721-6.50006-7 · Cited by 5
Abdulrehman, J., Forté, S., TOMLINSON, G. A., Solh, Z., Bolster, L., Sun, H., Bartolucci, P., & Kuo, K. H. M. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-079363 · Cited by 5
Doppler Imaging: Basic Principles and Clinical Application
Caldiera, V., Caputi, L., & Ciceri, E. F. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-25268-1_9 · Cited by 5
Dashe, J. F. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544897.048 · Cited by 5
Renaudier, P. (2008) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2008.09.013 · Cited by 5
Coagulation Abnormalities in Stroke
Coull, B. M., & Drake, K. W. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10041-7 · Cited by 5
Treatment strategies for childhood stroke
Eleftheriou, D., & Ganesan, V. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802521650 · Cited by 5
Neurocognitive Outcomes in Sickle Cell Disease
Armstrong, F. D., & Pavlakis, S. G. (2010) · Oxford University Press eBooks · doi:10.1093/oso/9780195342680.003.0033 · Cited by 5
Kwiatkowski, J. L. (2019) · JAMA · doi:10.1001/jama.2018.20390 · Cited by 5
Bernaudin, F., Verlhac, S., Ducros-Miralles, E., Arnaud, C., Genty, I., Petras, M., Paillard, C., Luna, G. D., Meunier, B., Thuret, I., et al. (2026) · American Journal of Hematology · doi:10.1002/ajh.70336 · Cited by 4
Zantek, N. D., Alquist, C. R., Hofmann, J. C., Klingel, R., Levenbrown, Y., Onwuemene, O. A., Patidar, G. K., Patriquin, C. J., Raval, J. S., Sanchez, A. P., et al. (2026) · Journal of Clinical Apheresis · doi:10.1002/jca.70141 · Cited by 4
Ambrose, E. E., Sabuni, P. A., Jason, D. P., Ware, R. E., Makubi, A. N., & Smart, L. R. (2025) · Blood Global Hematology · doi:10.1016/j.bglo.2025.100001 · Cited by 4
Jordan, L. C., Rodeghier, M., Donahue, M. J., & DeBaun, M. R. (2020) · American Journal of Hematology · doi:10.1002/ajh.25954 · Cited by 4
Zanfardino, S., Mazziotto, V., & Bodas, P. (2022) · Pediatric Blood & Cancer · doi:10.1002/pbc.29580 · Cited by 4
Comprehensive guide to managing a chronic automated red cell exchange program in sickle cell disease
Cunard, R. A., Gopal, S., Kopko, P. M., Dang, M., Hazle, K. M., & Sanchez, A. P. (2022) · Journal of Clinical Apheresis · doi:10.1002/jca.22014 · Cited by 4
Current and emerging drug treatment strategies to tackle sickle cell anemia
Persaud, Y., Leonard, A. K., & Rai, P. (2024) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2024.2379260 · Cited by 4
Lanzkowsky, P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375154-6.00008-2 · Cited by 4
Xie, Y., Pivnick, E. K., Cohen, H. L., Adams-Graves, P. E., Pourcyrous, M., Aygün, B., & Hankins, J. S. (2013) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3182678f68 · Cited by 4
Resolution of cerebral artery stenosis in a child with sickle cell anemia treated with hydroxyurea
Grace, R. F., Su, H., Sena, L. M., Poussaint, T. Y., Heeney, M. M., & Gutiérrez, A. (2009) · American Journal of Hematology · doi:10.1002/ajh.21596 · Cited by 4
Comprehensive healthcare for individuals with sickle cell disease
Cançado, R. D. (2011) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20110025 · Cited by 4
Transfusion therapy for sickle cell disease
Howard, J., & Robinson, S. E. (2016) · ISBT Science Series · doi:10.1111/voxs.12223 · Cited by 4
Khandros, E., & Kwiatkowski, J. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821671-2.00013-1 · Cited by 4
Posterior Circulation Evaluation in Patients with Sickle Cell Anemia
Adegoke, S. A., Figueiredo, M. S., Vicari, P., Carrete, H., Idagawa, M. H., Massaro, A. R., & Silva, G. S. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.11.007 · Cited by 4
Érythraphérèses chez l’enfant drépanocytaire, expérience d’une unité d’aphérèse pédiatrique
Lesprit, E., Missud, F., Arnould, A., Smaïne, D., & Benkerrou, M. (2021) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2021.09.002 · Cited by 4
Kambale‐Kombi, P., Djang'Eing'A, R. M., Opara, J. P. A., Minon, J., Sépulchre, E., Bours, V., Floch, A., Pirenne, F., Tshilumba, C. K., & Batina‐Agasa, S. (2022) · Transfusion Medicine · doi:10.1111/tme.12939 · Cited by 4
Neurocognitive function in sickle cell disease: have we been missing something?
Armstrong, F. D. (2010) · Expert Review of Hematology · doi:10.1586/ehm.10.59 · Cited by 4
The Role of Ultrasound in the Management of Cerebrovascular Disease
Alexandrov, A. V. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0631-6.50011-7 · Cited by 4
Hydroxyurea lowers TCD—and also stroke?
Adams, R. J. (2007) · Blood · doi:10.1182/blood-2007-05-086397 · Cited by 4
Cerebral Arteriopathies, Venous Thrombosis, and Migraine
Camargo, E. C., & Singhal, A. B. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1603914 · Cited by 4
GSTM1 and Liver Iron Content in Children with Sickle Cell Anemia and Iron Overload
Puri, L., Flanagan, J. M., Kang, G., Ding, J., Bi, W., McCarville, B. M., Loeffler, R. B., Tipirneni‐Sajja, A., Villavicencio, M., Crews, K. R., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111878 · Cited by 4
Bernaudin, F. (2020) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2019.12.002 · Cited by 4
Haematological Diseases in the Tropics
Thachil, J. V., Mbanya, D., & Bates, I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-7959-7.00069-5 · Cited by 4
Vasculopathy in sickle cell disease
Nur, E. (2011) · UvA-DARE (University of Amsterdam) · Cited by 4
Sarfo, F. S., Paintsil, V., Nyanor, I., Asafo‐Adjei, E., Ahmed, E. A., Nguah, S. B., Amuzu, E. X., Abubakar, S. Y., Osei‐Tutu, L., Oppong–Mensah, Y. G., et al. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123263 · Cited by 3
Promising role of voxelotor in managing sickle cell disease in children: a narrative review
Agrawal, A., Jadon, G., Singh, J., & Janjua, D. (2024) · Korean Journal of Pediatrics · doi:10.3345/cep.2024.00500 · Cited by 3
Current concepts in the management of stroke in children with sickle cell disease
Islam, M., & Anoop, P. (2011) · Child s Nervous System · doi:10.1007/s00381-011-1394-0 · Cited by 3
Therapeutic Cytapheresis, Plasmapheresis, and Plasma Exchange in Neoplastic Diseases of the Blood
Dutcher, J. P. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_54 · Cited by 3
Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
Rabinstein, A. A., Schor, N., & Verma, A. (2007) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(08)70039-5 · Cited by 3
Firth, P. G., & Kinane, T. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-42974-0.00013-6 · Cited by 3
Valentini, C. G., Teofili, L., & Gehrie, E. A. (2024) · British Journal of Haematology · doi:10.1111/bjh.19703 · Cited by 3
Jones, J. M., Wool, J., Crowe, E. P., Bloch, E. M., Pecker, L. H., & Lanzkron, S. (2024) · Transfusion · doi:10.1111/trf.18041 · Cited by 3
Sickle Cell Anemia: The Impact of Discovery, Politics, and Business
Xie, L., Doye, A. A., Conley, E., & Gwathmey, J. K. (2013) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2014.0008 · Cited by 3
Kwiatkowski, J. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801368-7.00011-9 · Cited by 3
Factors associated with abnormal cerebral blood flow in Egyptian children with sickle cell disease
Abd-Allah, F., Eltagui, M. H., fotouh, A. M. A., Kishk, N. A., Farrag, M. A., Mohammed, S. A., Shamloul, R. M., El-Jaafary, S. I., Said, F., Ibrahim, A. G.-E., et al. (2020) · Clinical and Translational Neuroscience · doi:10.1177/2514183x20911351 · Cited by 3
COVID-19 and SCA: an old friend comes to the rescue
Novelli, E. M. (2020) · Blood · doi:10.1182/blood.2020006442 · Cited by 3
Runge, A. S., Brazel, D., & Pakbaz, Z. (2021) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2021.1954285 · Cited by 3
Advances in pharmacotherapy for sickle cell disease: what is the current state of play?
Alan, S., & Kanter, J. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2377711 · Cited by 3
Unusual Causes of Ischaemic Stroke and Transient Ischaemic Attack
Warlow, C., van Gijn, J., Dennis, M. S., Wardlaw, J. M., Bamford, J., Hankey, G. J., Sandercock, P. A., Rinkel, G. J. E., Langhorne, P., Sudlow, C. L. M., et al. (2008) · Wiley eBooks · doi:10.1002/9780470696361.ch7 · Cited by 3
Greffe dans la drépanocytose : résultats, perspectives
Bernaudin, F. (2008) · Archives de Pédiatrie · doi:10.1016/s0929-693x(08)71857-8 · Cited by 3
Expert opinion on emerging drugs in childhood arterial ischemic stroke
Ng, J., & Ganesan, V. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.565050 · Cited by 3
Neurologic Complications of Hemoglobinopathies
Holmstedt, C. A., & Adams, R. J. (2011) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000394674.90243.a5 · Cited by 3
Transcranial Doppler Sonography
Ribó, M., & Alexandrov, A. V. (2010) · Springer eBooks · doi:10.1007/978-1-84882-957-2_6 · Cited by 3
Wolf, M., Cangemi, C., Drachtman, R. A., & Masterson, M. (2008) · Pediatric Hematology and Oncology · doi:10.1080/08880010802106655 · Cited by 3
Hepatopulmonary syndrome associated with iron overload in sickle cell anaemia
Grinnan, D., Herlihy, A. N., & Smith, W. R. (2012) · European Respiratory Journal · doi:10.1183/09031936.00199411 · Cited by 3
Hematologic Disorders and Stroke
Bushnell, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29544-4.00042-6 · Cited by 3
Stroke and Sickle Cell Disease
Ostendorf, A., Roach, E. S., & Adams, R. J. (2017) · Primer on Cerebrovascular Diseases · doi:10.1016/b978-0-12-803058-5.00118-1 · Cited by 3
The Role of Ultrasound in the Management of Cerebrovascular Disease
Alexandrov, A. V., & Balucani, C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1417-3.00005-x · Cited by 3
Deferasirox for managing transfusional iron overload in people with sickle cell disease
Meerpohl, J. J., Antes, G., Rücker, G., McLeod, C., Fleeman, N., Niemeyer, C. M., & Bassler, D. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007477 · Cited by 3
Kshatriya, G. S., & Sharma, S. (2025) · Cureus · doi:10.7759/cureus.92371 · Cited by 2
Optimizing the right time to start sickle cell therapies
Martin, O. Y., & Jacob, S. A. (2025) · Hematology · doi:10.1182/hematology.2025000752 · Cited by 2
Neurologic Complications of Hematologic Disorders
Patrick, L. M., & Terrelonge, M. (2026) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/cont.0000000000001660 · Cited by 2
Sickle Cell Disease: From Ancient Origins to Modern Breakthroughs in Gene Therapy
Ikolo, B. T., Oyelami, M., Mgbeke, O. E., Jones, K., Thomas, S., & Ikolo, F. (2026) · Biomedicines · doi:10.3390/biomedicines14071649 · Cited by 2
Bello‐Manga, H., Abdullahi, S. U., Hassab, H., Brown, B. J., Nduba, V., Githanga, J. N., Akinsete, A. M., El-Beshlawy, A. M., Hanna, D. A., Segbefia, C. I., et al. (2026) · American Journal of Hematology · doi:10.1002/ajh.70457 · Cited by 2
Self-citationKarimi, M., Haghpanah, S., Ashjazadeh, N., Shariat, A., Nazeri, M., Emami, S., Foroughi, A. A., Petramfar, P., & Yaghoubi, E. (2012) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612461068 · Cited by 2
Hematologic Emergencies in the PICU
Kneyber, M. C. J. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6416-6_20 · Cited by 2
Buckley, E. M., Platt, M. O., & Lam, W. A. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.08.008 · Cited by 2
Haemoglobinopathy: considerations for reproductive health
Supramaniam, P. R., Mittal, M., Hay, D., Narvekar, N. N., Lim, L. N., & Becker, C. M. (2018) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12513 · Cited by 2
Anemia at the Extremes of Life: Congenital Hemolytic Anemia
Reinish, A. L., & Noronha, S. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-96487-4_6 · Cited by 2
Genetic Basis of Stroke Occurrence, Prevention, and Outcome
Meschia, J. F., & Fornage, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00019-3 · Cited by 2
Knowledge and DdeI Based Confirmation of Sickle Cell Anemia Among the Tharu Community.
Ghaju, S., Khadayat, K., Shrestha, R., Ghaju, S., Manandhar, T., & Marasini, B. P. (2022) · Journal of Nepal Health Research Council · doi:10.33314/jnhrc.v20i02.4158 · Cited by 2
An innovative intervention for the prevention of vaso-occlusive episodes in sickle cell disease
Jeon, W. J., Joung, B., Moon, J. H., Hino, C., Park, D., Pham, B., Castillo, D. R., Chong, E. G., Kaur, S., Grismore, C., et al. (2023) · Hematology · doi:10.1080/16078454.2023.2215575 · Cited by 2
Hematologic Disorders and the Nervous System
Mauermann, M. L., & Southerland, A. M. (2023) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001238 · Cited by 2
Médecine transfusionnelle : au-delà de l’apport de facteurs déficitaires
Driss, F., Saheb, S., Garraud, O., & Heschmati, F. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2014.07.025 · Cited by 2
Enfermedad de células falciformes: papel del pediatra
Solà, S. R. (2013) · Anales de Pediatría Continuada · doi:10.1016/s1696-2818(13)70128-8 · Cited by 2
Stroke and Cerebrovascular Diseases
Munot, P., deVeber, G., & Ganesan, V. (2013) · Springer eBooks · doi:10.1007/978-0-85729-491-3_16 · Cited by 2
Stroke as a Complication of General Medical Disorders
George, P. M., & Albers, G. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407710-2.00011-4 · Cited by 2
Augustina, Ef, A., & Nu, M. (2017) · Cited by 2
Stem Cell Transplantation for Hemoglobinopathies
Wu, C. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-438-4_11 · Cited by 2
Majersik, J. J. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1603952 · Cited by 2
Keiser, A., Booth, G. S., & Gehrie, E. A. (2018) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2018.03.004 · Cited by 2
Genetics and Genomics of Stroke
Tan, R. Y. Y., & Markus, H. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-66114-8_24 · Cited by 2
Dalle, J. (2020) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2019.12.013 · Cited by 2
Neurologic and Cognitive Outcomes in Sickle Cell Disease from Infancy through Adolescence
Mayer, S. L., Fields, M. E., & Hulbert, M. L. (2021) · NeoReviews · doi:10.1542/neo.22-8-e531 · Cited by 2
Transcranial Doppler Sonography
Barlinn, K., & Alexandrov, A. V. (2021) · Springer eBooks · doi:10.1007/978-3-030-49616-6_15-1 · Cited by 2
Transcranial Doppler Sonography
Barlinn, K., & Alexandrov, A. V. (2017) · Springer eBooks · doi:10.1007/978-3-319-54760-2_15 · Cited by 2
Krementz, N. A., Gardener, H. E., Torres, L. F., Alkhalifah, M. M., Campo‐Bustillo, I., Campo, N., Koch, S., Alvarez, O. A., Rundek, T., & Romano, J. G. (2022) · Journal of Clinical Ultrasound · doi:10.1002/jcu.23182 · Cited by 2
LaRovere, K. L., & O'Brien, N. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-96893-9_19 · Cited by 2
Hematopoietic Cell Transplantation for Sickle Cell Disease
Walters, M. C. (2003) · Wiley eBooks · doi:10.1002/9780470987070.ch104 · Cited by 2
SYSTEMIC DISORDERS THAT ALSO INVOLVE THE CEREBROVASCULAR SYSTEM
Caplan, L. R., & Bogousslavsky, J. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544897.044 · Cited by 2
Seguimento de recém-nascidos, crianças e adolescentes com acidente vascular cerebral isquêmico
Ranzan, J. (2008) · Americanae (AECID Library) · Cited by 2
Kwiatkowski, J. L. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22349 · Cited by 2
Jarduli, L. R. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2018.tde-27062018-080953 · Cited by 2
Correction of the Sickle Cell Mutation Through Base and Prime Editing in Hematopoietic Stem CellsPreprint
Ji, K. (2020) · Preprints.org · doi:10.20944/preprints202009.0490.v1 · Cited by 2
Kossorotoff, M. (2014) · theses.fr (ABES) · doi:10.70675/386bd838z1261z4d11z98b5z804b41a8ceca · Cited by 2
Metadata
- Authors
- The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators
- Affiliations
- Augusta University (US)
- Corresponding author
- The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-12-29
- Volume
- 353
- Issue
- 26
- Pages
- 2769-2778
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1498156640
- Cited by
- 635
- References
- 27
- Citations by year
- 2026: 23 · 2025: 12 · 2024: 31 · 2023: 22 · 2022: 29 · 2021: 27 · 2020: 34 · 2019: 25 · 2018: 35 · 2017: 37 · 2016: 43 · 2015: 25 · 2014: 32 · 2013: 32 · 2012: 45
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (U01HL052193, U01HL052016)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- sickle cell disease, stroke prevention, prophylactic transfusion, transcranial Doppler screening, cerebral blood flow velocity, children
- MeSH terms
- Adolescent, Adult, Anemia, Sickle Cell, Blood Flow Velocity, Blood Transfusion, Brain, Child, Female, Humans, Magnetic Resonance Imaging, Male, Risk, Chelation Therapy, Ultrasonography, Doppler, Transcranial, Stroke, Middle Cerebral Artery, Withholding Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.